(Source: Business Wire)
Owens & Minor (NYSE:OMI) today reported financial results for
the third quarter ended September 30, 2009, including record quarterly
revenue of $2.03 billion, increased 13.9% when compared to revenue of
$1.79 billion in the third quarter of 2008. Income from continuing
operations for the quarter was $34.7 million, or $0.83 per diluted
share, increased 36.8% when compared to $25.3 million, or $0.61 per
diluted share, in the same period last year. Net income for the third
quarter was $34.7 million, or $0.83 per diluted share, increased 37.2%
when compared to net income in the same quarter of 2008.
In the third quarter of 2009, the company reported gross margin of
$204.3 million, or 10.04% of revenues, compared to $178.7 million, or
10.00% of revenues, for the third quarter of 2008. The increase in gross
margin dollars for the third quarter 2009 was the result of an increase
in revenues. Also during the third quarter, gross margin benefitted from
the overall positive impact of supplier price changes. As expected, one
of the company's suppliers significantly reduced its prices on a certain
set of products, resulting in a credit for the provision for last-in,
first-out (LIFO) inventory valuation of $11.5 million, net of the effect
of other suppliers' price increases.
"As we enter the home stretch of 2009, we are pleased with revenue
gains, operating earnings improvement, and positive cash flows, but
recognize that we are challenged with lower profitability from some of
our new and acquired customers," said Craig R. Smith, president & chief
executive officer of Owens & Minor. "As we have done before, we will
work with these new customers to improve operating margins. Looking
ahead, we will continue to focus on achieving the potential of the
Burrows acquisition, while building out our strategic initiatives, which
are designed to broaden our reach and position our company to capture
growth opportunities in healthcare."
Year-to-Date Results
For the nine months ended September 30, 2009, revenue was $6.00 billion,
improved 13.5% from revenue of $5.29 billion in the same period last
year. Income from continuing operations for the first nine months of the
year was $84.8 million, or $2.03 per diluted share, compared favorably
to income from continuing operations of $73.8 million, or $1.78 per
diluted share, for the comparable period last year. Net income for the
first nine months of 2009 was $72.3 million, or $1.73 per diluted share,
decreased from net income of $73.1 million, or $1.76 per diluted share
in the same period last year. For comparative purposes, results for the
first nine months of 2009 reflect the January 2009 sale of certain
assets of the company's direct-to-consumer diabetes supply (DTC)
business, shown as discontinued operations for all periods presented.
Therefore, year-to-date results reflect a loss from discontinued
operations of $12.5 million, or $0.30 per diluted share, resulting
primarily from pre-tax charges associated with exiting the DTC business.
Results for the first nine months of 2009 also reflect the impact of
transitioning the business acquired in The Burrows Company transaction.
Asset Management
For the year-to-date period 2009, operating cash flow from continuing
operations was $161.5 million, increased when compared to $119.1 million
last year in the same period. Cash provided by discontinued operations
for the same period was $73.6 million, including $63 million received in
January 2009 from the sale of certain assets of the DTC business.
Long-term debt as of the end of the third quarter 2009 was $208 million,
consistent with the third quarter last year. Days sales outstanding
(DSO) as of September 30, 2009, continued on a strong trend at 23.0
days, improved slightly when compared to DSO of 23.2 days in the same
period last year. Inventory turns of 10.5 for the third quarter of 2009
were improved from turns of 10.3 in the prior year third quarter.
2009 Outlook
"As we approach the end of 2009, we continue to target revenue growth
for the year in the upper end of a range of 8% to 12%, and income per
diluted share from continuing operations in the range of $2.55 to $2.70,
excluding the positive effect of the third quarter LIFO provision," said
Smith.
The 2009 outlook is based on certain assumptions that are subject to the
risk factors discussed in the company's filings with the Securities &
Exchange Commission.
Upcoming Investor Events
On Thursday, November 5, 2009, Owens & Minor will hold an Open House &
Facility Tour at its distribution center in Richmond, Virginia, for
Wall Street analysts and professional investors. The event will focus
on operations and will feature tours of the 165,000 square-foot
facility, the specialized SurgiTrackSM area, and
demonstrations of the company's newly installed voice-pick technology
and automation equipment. The event is scheduled to begin at 9:30 a.m.
ET and conclude at approximately 2:00 p.m. ET.
On Thursday, December 10, 2009, Owens & Minor will host a 2010
Financial Outlook Meeting in New York City. Owens & Minor's President
& Chief Executive Officer Craig R. Smith and Chief Financial Officer
James L. Bierman are scheduled to speak at the event, discussing
progress on strategic initiatives and providing the company's
financial outlook for 2010. The meeting is scheduled to begin at 8:30
a.m. ET and conclude at approximately 10:30 a.m. ET. A live,
listen-only webcast of the briefing can be accessed on the company
website at www.owens-minor.com
under the Investor Relations Section. A webcast replay of the event
will also be available on the company website.
Safe Harbor Statement
Except for historical information, the matters discussed in this press
release may constitute forward-looking statements that involve risks and
uncertainties that could cause actual results to differ materially from
those projected. These risk factors are discussed in reports filed by
the company with the Securities & Exchange Commission. All of this
information is available at www.owens-minor.com.
The company assumes no obligation, and expressly disclaims any such
obligation, to update or alter information, whether as a result of new
information, future events, or otherwise.
Owens & Minor, Inc.,
(NYSE: OMI) a FORTUNE 500 company headquartered in Richmond,
Virginia, is a leading distributor of national name-brand medical and
surgical supplies and a healthcare supply-chain management company.
Owens & Minor is also a member of the Russell 2000® Index,
which measures the performance of the small-cap segment of the U.S.
equity universe, as well as the S&P MidCap 400, which includes companies
with a market capitalization of $750 million to $3.3 billion that meet
certain financial standards. With a diverse product and service offering
and distribution centers throughout the United States, the company
serves hospitals, integrated healthcare systems, alternate care
locations, group purchasing organizations, and the federal government.
Owens & Minor provides technology and consulting programs that improve
inventory management and streamline logistics across the entire medical
supply chain--from origin of product to patient bedside. For news
releases, or for more information about Owens & Minor, visit the company
Web site at www.owens-minor.com.
Investors Conference Call &
Supplemental Material
Conference Call: Owens & Minor will conduct a conference call for
investors on Tuesday, October 27, 2009, at 8:30 a.m. ET. Participants
may access the call at 877-748-0043 with access code #34676277. The
international dial-in number is 706-758-5871 with access code #34676277. Webcast:
Replay: A replay of the call will be available for three weeks by
dialing 800-642-1687, using access code #34676277. A listen-only webcast
of the call, along with supplemental information, will be available
on www.owens-minor.com
under "Investor Relations." Owens & Minor uses its Web site as a channel
of distribution for material company information, including news
releases, investor presentations and financial information. This
information is routinely posted and accessible under the Investor
Relations section.
Owens & Minor, Inc.Condensed Consolidated Statements of Income (unaudited)(in thousands, except per share data)
Three Months Ended September 30,
2009 2008
Revenue $ 2,034,792 $ 1,786,858
Cost of revenue 1,830,450 1,608,109
Gross margin 204,342 178,749
Selling, general and administrative expenses 142,162 128,656
Depreciation and amortization 6,721 5,667
Other operating income, net (1,233 ) (1,893 )
Operating earnings 56,692 46,319
Interest expense, net 3,202 6,284
Income before income taxes 53,490 40,035
Income tax provision 18,803 14,687
Income from continuing operations 34,687 25,348
Loss from discontinued operations, net of tax - (64 )
Net income $ 34,687 $ 25,284
Income (loss) per share - basic:
Continuing operations $ 0.83 $ 0.62
Discontinued operations $ - $ (0.01 )
Net income per share - basic $ 0.83 $ 0.61
Income (loss) per share - diluted:
Continuing operations $ 0.83 $ 0.61
Discontinued operations $ - $ -
Net income per share - diluted $ 0.83 $ 0.61
Weighted average shares - basic 41,205 40,860
Weighted average shares - diluted 41,859 41,544
Nine Months Ended September 30,
2009 2008
Revenue $ 5,997,200 $ 5,285,389
Cost of revenue 5,411,526 4,761,084
Gross margin 585,674 524,305
Selling, general and administrative expenses 425,531 380,386
Depreciation and amortization 18,583 16,343
Other operating income, net (3,958 ) (4,811 )
Operating earnings 145,518 132,387
Interest expense, net 9,834 12,660
Income before income taxes 135,684 119,727
Income tax provision 50,864 45,879
Income from continuing operations 84,820 73,848
Loss from discontinued operations, net of tax (12,509 ) (724 )
Net income $ 72,311 $ 73,124
Income (loss) per share - basic:
Continuing operations $ 2.04 $ 1.80
Discontinued operations $ (0.30 ) $ (0.02 )
Net income per share - basic $ 1.74 $ 1.78
Income (loss) per share - diluted:
Continuing operations $ 2.03 $ 1.78
Discontinued operations $ (0.30 ) $ (0.02 )
Net income per share - diluted $ 1.73 $ 1.76
Weighted average shares - basic 41,091 40,744
Weighted average shares - diluted 41,724 41,436
-------------------------------------------------------------------------------
Owens & Minor, Inc.Condensed Consolidated Balance Sheets (unaudited)(in thousands)
September 30, 2009 December 31, 2008
Assets
Current assets
Cash and cash equivalents $ 42,931 $ 7,886
Accounts and notes receivable, net 509,497 521,311
Merchandise inventories 679,459 679,069
Other current assets 60,911 71,329
Current assets of discontinued operations - 32,199
Total current assets 1,292,798 1,311,794
Property and equipment, net 82,667 76,949
Property held for sale 12,730 15,730
Goodwill, net 247,271 252,412
Intangible assets, net 28,571 27,802
Other assets, net 32,988 29,145
Other assets of discontinued operations - 62,358
Total assets $ 1,697,025 $ 1,776,190
Liabilities and shareholders' equity
Current liabilities
Accounts payable $ 548,929 $ 513,026
Accrued payroll and related liabilities 23,128 40,018
Other accrued liabilities 111,263 103,429
Current liabilities of discontinued operations 2,603 11,038
Total current liabilities 685,923 667,511
Long-term debt, excluding current portion 207,999 359,237
Other liabilities 57,601 60,391
Total liabilities 951,523 1,087,139
Shareholders' equity
Common stock 83,786 82,881
Paid-in capital 191,655 180,074
Retained earnings 481,735 438,192
Accumulated other comprehensive loss (11,674) (12,096)
Total shareholders' equity 745,502 689,051
Total liabilities and shareholders' equity $ 1,697,025 $ 1,776,190
-------------------------------------------------------------------------------
Owens & Minor, Inc.Condensed Consolidated Statements of Cash Flows (unaudited)(in thousands)
Nine Months Ended September 30,
2009 2008
Operating activities:
Net income $ 72,311 $ 73,124
Adjustments to reconcile net income to cash provided by operating activities of continuing operations:
Loss from discontinued operations 12,509 724
Depreciation and amortization 18,583 16,343
Share-based compensation expense 5,860 6,129
Provision for LIFO reserve 4,940 10,468
Provision for losses on accounts and notes receivable 3,387 2,368
Loss on interest rate swaps - 3,141
Changes in operating assets and liabilities:
Accounts and notes receivable 8,427 (10,940 )
Merchandise inventories (5,330 ) (38,258 )
Accounts payable 48,485 46,194
Net change in other current assets and current liabilities (4,552 ) 8,472
Other, net (3,160 ) 1,346
Cash provided by operating activities of continuing operations 161,460 119,111
Investing activities:
Additions to property and equipment (14,123 ) (12,586 )
Additions to computer software (9,311 ) (5,510 )
Cash received related to acquisition of business 6,994 -
Proceeds from the sale of property and equipment 2,398 -
Other, net - 8
Cash used for investing activities of continuing operations (14,042 ) (18,088 )
Financing activities:
Net payments on revolving credit facility (150,578 ) (76,908 )
Cash dividends paid (28,755 ) (24,733 )
Increase (decrease) in drafts payable (12,582 ) 634
Proceeds from exercise of stock options 5,228 8,140
Excess tax benefits related to share-based compensation 2,306 2,963
Proceeds from termination of interest rate swaps - 3,795
Other, net (1,604 ) (1,911 )
Cash used for financing activities of continuing operations (185,985 ) (88,020 )
Discontinued operations:
Operating cash flows 10,612 4,452
Investing cash flows 63,000 (2,109 )
Net cash provided by discontinued operations 73,612 2,343
Net increase in cash and cash equivalents 35,045 15,346
Cash and cash equivalents at beginning of period 7,886 10,395
Cash and cash equivalents at end of period $ 42,931 $ 25,741
-------------------------------------------------------------------------------
Owens & Minor, Inc.Financial Statistics (unaudited)
Quarter Ended
(in thousands, except ratios and per share data) 9/30/2009 6/30/2009 3/31/2009 12/31/2008 9/30/2008
Operating results:
Revenue $ 2,034,792 $ 2,013,780 $ 1,948,628 $ 1,957,848 $ 1,786,858
Gross margin $ 204,342 $ 197,699 $ 183,633 $ 192,956 $ 178,749
Gross margin as a percent of revenue 10.04% 9.82% 9.42% 9.86% 10.00%
SG&A expense $ 142,162 $ 143,972 $ 139,397 $ 141,015 $ 128,656
SG&A expense as a percent of revenue 6.99% 7.15% 7.15% 7.20% 7.20%
Operating earnings $ 56,692 $ 48,946 $ 39,880 $ 48,338 $ 46,319
Operating earnings as a percent of revenue 2.79% 2.43% 2.05% 2.47% 2.59%
Income from continuing operations $ 34,687 $ 27,775 $ 22,358 $ 27,409 $ 25,348
Loss from discontinued operations, net of tax $ - $ (4,127) $ (8,382) $ (7,206) $ (64)
Net income $ 34,687 $ 23,648 $ 13,976 $ 20,203 $ 25,284
Income (loss) per common share - basic:
Continuing operations $ 0.83 $ 0.67 $ 0.54 $ 0.66 $ 0.62
Discontinued operations $ - $ (0.10) $ (0.20) $ (0.17) $ (0.01)
Net income per share - basic $ 0.83 $ 0.57 $ 0.34 $ 0.49 $ 0.61
Income (loss) per common share - diluted:
Continuing operations $ 0.83 $ 0.67 $ 0.54 $ 0.66 $ 0.61
Discontinued operations $ - $ (0.10) $ (0.20) $ (0.17) $ -
Net income per share - diluted $ 0.83 $ 0.57 $ 0.34 $ 0.49 $ 0.61
Accounts receivable:
Accounts and notes receivable, net ((2)) $ 509,497 $ 500,204 $ 511,875 $ 521,311 $ 449,988
Days sales outstanding ((1) (2)) 23.0 22.6 23.6 24.5 23.2
Inventory:
Merchandise inventories ((2)) $ 679,459 $ 696,955 $ 702,253 $ 679,069 $ 605,711
Average inventory turnover ((1) (2)) 10.5 10.4 10.3 10.9 10.3
Financing:
Long-term debt, excluding current portion $ 207,999 $ 208,326 $ 212,596 $ 359,237 $ 208,832
Stock information:
Cash dividends per common share $ 0.23 $ 0.23 $ 0.23 $ 0.20 $ 0.20
Stock price at quarter-end $ 45.25 $ 43.82 $ 33.13 $ 37.65 $ 48.50
((1) )Days sales outstanding and average inventory turnover are based on three-months' sales.
((2) )Based on results from continuing operations.
Certain adjustments have been made to prior period amounts to conform to current year presentation.
-------------------------------------------------------------------------------
A service of YellowBrix, Inc.
